Grace Therapeutics, Inc. — Form D

Grace Therapeutics, Inc. of Princeton, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-02. $170K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Michel ChartrandDirectorLAVAL, A8
Ronald DenisDirectorLaval, A8
MARTIN GODBOUTDirectorMONTREAL, A8
Henri HarlandDirectorLAVAL, A8
Marc LebelDirectorChelmsford, MA
Henri HarlandExecutive OfficerLAVAL, A8
Xavier HarlandExecutive OfficerLAVAL, A8
Tina SampalisExecutive OfficerLAVAL, A8
Donald OldsDirectorMcLean, VA
Robert J. DelAversanoExecutive OfficerPrinceton, NJ
Amresh KumarExecutive OfficerPrinceton, NJ
Prashant KohliDirectorPrinceton, NJ
Prashant KohliExecutive OfficerPrinceton, NJ
Carrie D'AndreaExecutive OfficerPrinceton, NJ
S. George KottayilDirectorPrinceton, NJ
Edward NeugeborenDirectorPrinceton, NJ
A. Brian DavisDirectorWinston-Salem, NC
Dr. R. Loch MacdonaldExecutive OfficerPrinceton, NJ
Vimal KavuruDirectorPrinceton, NJ
Brian FordExecutive OfficerCharlotte, NC
Michael DerbyDirectorLaval, A8
Jean-Marie (John) N CananDirectorLaval, A8
Linda P O'KeefeExecutive OfficerLaval, A8
Donald N OldsDirectorLaval, A8
Roderick N CarterDirectorLaval, A8

Other filings by this issuer (3)

FiledFormOfferingSold
2025-02-25D$30.0M$15.0M
2023-10-10D$15.1M$7.5M
2018-05-25D$838K$373K

More